FDA — authorised 23 November 1962
- Marketing authorisation holder: ENDO PHARMS
- Status: approved
FDA authorised Valpin on 23 November 1962
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA authorised it on 23 November 1962.
ENDO PHARMS holds the US marketing authorisation.